Cargando…
Prophylactic Treatment for Patients with Migraine Using Blue Cut for Night Glass
OBJECTIVES: Migraine is a disease that leads to social loss due to a decrease in productivity since it is a primary headache with a high prevalence and readily occurs in working-age persons. As described in the diagnostic criteria of the International Classification of Headache Disorders, 3rd editio...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076141/ https://www.ncbi.nlm.nih.gov/pubmed/35989269 http://dx.doi.org/10.2169/internalmedicine.0132-22 |
_version_ | 1785020072835678208 |
---|---|
author | Tatsumoto, Muneto Suzuki, Eiji Nagata, Mayumi Suzuki, Keisuke Hirata, Koichi |
author_facet | Tatsumoto, Muneto Suzuki, Eiji Nagata, Mayumi Suzuki, Keisuke Hirata, Koichi |
author_sort | Tatsumoto, Muneto |
collection | PubMed |
description | OBJECTIVES: Migraine is a disease that leads to social loss due to a decrease in productivity since it is a primary headache with a high prevalence and readily occurs in working-age persons. As described in the diagnostic criteria of the International Classification of Headache Disorders, 3rd edition (beta version), migraine causes hypersensitivity, especially photosensitivity, during attacks, suggesting that light is an inducer of headaches. We developed Blue Cut for Night (BCN) glass, which reduces light stimulation to intrinsically photosensitive continental ganglion cells (ipRGCs), photoreceptors that can lead to exacerbation of migraine attacks. METHODS: Ten patients with migraine participated in the study. Each participant was made to wear BCN glasses only at night for four weeks. The number of headache days and Headache Impact Test-6 values before and after using the BCN glasses were compared. RESULTS: When the 10 patients with migraine wore the BCN glass at night only for 4 weeks, the number of headache days within that time tended to decrease (7.0±4.37 days) compared to before wearing the glasses (8.7±5.03 days). No participants had any side effects. CONCLUSION: BCN glass, which reduces light stimulation to ipRGCs, was suggested to be a tool for reducing migraine attacks. |
format | Online Article Text |
id | pubmed-10076141 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Japanese Society of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-100761412023-04-06 Prophylactic Treatment for Patients with Migraine Using Blue Cut for Night Glass Tatsumoto, Muneto Suzuki, Eiji Nagata, Mayumi Suzuki, Keisuke Hirata, Koichi Intern Med Original Article OBJECTIVES: Migraine is a disease that leads to social loss due to a decrease in productivity since it is a primary headache with a high prevalence and readily occurs in working-age persons. As described in the diagnostic criteria of the International Classification of Headache Disorders, 3rd edition (beta version), migraine causes hypersensitivity, especially photosensitivity, during attacks, suggesting that light is an inducer of headaches. We developed Blue Cut for Night (BCN) glass, which reduces light stimulation to intrinsically photosensitive continental ganglion cells (ipRGCs), photoreceptors that can lead to exacerbation of migraine attacks. METHODS: Ten patients with migraine participated in the study. Each participant was made to wear BCN glasses only at night for four weeks. The number of headache days and Headache Impact Test-6 values before and after using the BCN glasses were compared. RESULTS: When the 10 patients with migraine wore the BCN glass at night only for 4 weeks, the number of headache days within that time tended to decrease (7.0±4.37 days) compared to before wearing the glasses (8.7±5.03 days). No participants had any side effects. CONCLUSION: BCN glass, which reduces light stimulation to ipRGCs, was suggested to be a tool for reducing migraine attacks. The Japanese Society of Internal Medicine 2022-08-20 2023-03-15 /pmc/articles/PMC10076141/ /pubmed/35989269 http://dx.doi.org/10.2169/internalmedicine.0132-22 Text en Copyright © 2023 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Tatsumoto, Muneto Suzuki, Eiji Nagata, Mayumi Suzuki, Keisuke Hirata, Koichi Prophylactic Treatment for Patients with Migraine Using Blue Cut for Night Glass |
title | Prophylactic Treatment for Patients with Migraine Using Blue Cut for Night Glass |
title_full | Prophylactic Treatment for Patients with Migraine Using Blue Cut for Night Glass |
title_fullStr | Prophylactic Treatment for Patients with Migraine Using Blue Cut for Night Glass |
title_full_unstemmed | Prophylactic Treatment for Patients with Migraine Using Blue Cut for Night Glass |
title_short | Prophylactic Treatment for Patients with Migraine Using Blue Cut for Night Glass |
title_sort | prophylactic treatment for patients with migraine using blue cut for night glass |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076141/ https://www.ncbi.nlm.nih.gov/pubmed/35989269 http://dx.doi.org/10.2169/internalmedicine.0132-22 |
work_keys_str_mv | AT tatsumotomuneto prophylactictreatmentforpatientswithmigraineusingbluecutfornightglass AT suzukieiji prophylactictreatmentforpatientswithmigraineusingbluecutfornightglass AT nagatamayumi prophylactictreatmentforpatientswithmigraineusingbluecutfornightglass AT suzukikeisuke prophylactictreatmentforpatientswithmigraineusingbluecutfornightglass AT hiratakoichi prophylactictreatmentforpatientswithmigraineusingbluecutfornightglass |